drugset / Trial / NCT03748758
Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this study is to evaluate the safety and tolerability of two dose levels of OP0201 and placebo, when administered intranasally in healthy adults subjects.
Timeline
- Start
- 2018-11-27
- Primary completion
- 2019-03-20
- Completion
- 2019-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OP0201 | Unknown | 30 mg | Intranasal |
| Subject | OP0201 | Unknown | 60 mg | Intranasal |
Indications
No indication recorded.